ROCKVILLE, Md., April 27, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report business results for the first quarter of 2021 after the market closes on Wednesday, May 5, 2021.

See the article here:
Supernus to Host First Quarter 2021 Financial Results Conference Call

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh